Panacea Life Sciences Holdings annual operating margin
2014
2015
2019
2020
2021
2022
2023
Panacea Life Sciences Holdings Operating Margin Growth & History (PLSH)
Panacea Life Sciences Holdings's operating margin was −232.55% for fiscal 2023.
View full Panacea Life Sciences Holdings company overviewPanacea Life Sciences Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −232.55% | +114.86 pp |
| 2022 | 2022-12-31 | −347.41% | −59.14 pp |
| 2021 | 2021-12-31 | −288.26% | −229.96 pp |
| 2020 | 2020-12-31 | −58.31% | +3029.16 pp |
| 2019 | 2019-12-31 | −3,087.46% | +179674.04 pp |
| 2015 | 2015-12-31 | −182,761.50% | −133435.45 pp |
| 2014 | 2014-12-31 | −49,326.06% | — |
Panacea Life Sciences Holdings quarterly operating margin
Q2.14
Q3.14
Q4.15
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2024 | 2024-03-31 | −100.09% | +90.32 pp |
| Q4 2023 | 2023-12-31 | −184.07% | +239.45 pp |
| Q3 2023 | 2023-09-30 | −406.52% | −27.34 pp |
| Q2 2023 | 2023-06-30 | −269.11% | −4.99 pp |
| Q1 2023 | 2023-03-31 | −190.41% | +162.88 pp |
| Q4 2022 | 2022-12-31 | −423.52% | −238.04 pp |
| Q3 2022 | 2022-09-30 | −379.18% | −165.24 pp |
| Q2 2022 | 2022-06-30 | −264.13% | +195.02 pp |
| Q1 2022 | 2022-03-31 | −353.29% | −341.67 pp |
| Q4 2021 | 2021-12-31 | −185.48% | +63.72 pp |
| Q3 2021 | 2021-09-30 | −213.94% | −226.97 pp |
| Q2 2021 | 2021-06-30 | −459.15% | −144.12 pp |
| Q4 2020 | 2020-12-31 | −11.61% | +2356.91 pp |
| Q3 2020 | 2020-09-30 | −249.20% | +3110.01 pp |
| Q2 2020 | 2020-06-30 | 13.03% | +2050.72 pp |
| Q1 2020 | 2020-03-31 | −315.02% | +15929.37 pp |
| Q4 2019 | 2019-12-31 | −2,368.53% | +54159.64 pp |
| Q3 2019 | 2019-09-30 | −3,359.21% | +31800.89 pp |
| Q2 2019 | 2019-06-30 | −2,037.70% | +5991.41 pp |
| Q1 2019 | 2019-03-31 | −16,244.39% | — |
| Q4 2015 | 2015-12-31 | −56,528.17% | — |
| Q3 2014 | 2014-09-30 | −35,160.09% | — |
| Q2 2014 | 2014-06-30 | −8,029.11% | — |
Panacea Life Sciences Holdings operating margin trends
Over the last five reported fiscal years, Panacea Life Sciences Holdings's operating margin increased from −182,761.50% to −232.55%, a change of +182528.95 percentage points. The latest reported quarter, Q1 2024, shows −100.09%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Panacea Life Sciences Holdings filings at SEC.gov ↗